This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yajima, M. Articles by Takada, K. Search for Related Content PubMed PubMed Citation Articles by Yajima, M. Articles by Takada, K.

 Previous Article  |  Next Article 

Journal of Virology, April 2005, p. 4298-4307, Vol. 79, No. 7
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.7.4298-4307.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Critical Role of Epstein-Barr Virus (EBV)-Encoded RNA in Efficient EBV-Induced B-Lymphocyte Growth Transformation

Department of Tumor Virology,¹ Center for Virus Vector Development, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan²

Received 25 June 2004/ Accepted 5 November 2004

It was demonstrated that Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) were nonessential for B-lymphocyte growth transformation. We revisited this issue by producing a large quantity of EBER-deleted EBV by using an Akata cell system. Although the EBER-deleted virus efficiently infected B lymphocytes, its 50% transforming dose was approximately 100-fold less than that of the EBER-positive EBV. We then engineered the genome of EBER-deleted virus and generated a recombinant virus with the EBER genes reconstituted at their native locus. The resultant EBER-reconstituted EBV exhibited restored transforming ability. In addition, lymphoblastoid cell lines established with the EBER-deleted EBV grew significantly more slowly than those established with wild-type or EBER-reconstituted EBV, and the difference between the growth rates was especially highlighted when the cells were plated at low cell densities. These results clearly demonstrate that EBERs significantly contribute to the efficient growth transformation of B lymphocytes by enhancing the growth potential of transformed lymphocytes.

This article has been cited by other articles:

• Wu, Y., Maruo, S., Yajima, M., Kanda, T., Takada, K. (2007). Epstein-Barr Virus (EBV)-Encoded RNA 2 (EBER2) but Not EBER1 Plays a Critical Role in EBV-Induced B-Cell Growth Transformation. J. Virol. 81: 11236-11245 [Abstract] [Full Text]  
• Garcia, M. A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C., Esteban, M. (2006). Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action. Microbiol. Mol. Biol. Rev. 70: 1032-1060 [Abstract] [Full Text]  
• Emura, F., Saito, D., Kakizoe, T., Blaser, M. J. (2006). Infection, Cancer and Prevention: Report of the 19th International Symposium of the Foundation for Promotion of Cancer Research. Jpn J Clin Oncol 36: 745-755 [Full Text]  
• Fok, V., Friend, K., Steitz, J. A. (2006). Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling. J. Cell Biol. 173: 319-325 [Abstract] [Full Text]  
• Fok, V., Mitton-Fry, R. M., Grech, A., Steitz, J. A. (2006). Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22. RNA 12: 872-882 [Abstract] [Full Text]  
• Ruf, I. K., Lackey, K. A., Warudkar, S., Sample, J. T. (2005). Protection from Interferon-Induced Apoptosis by Epstein-Barr Virus Small RNAs Is Not Mediated by Inhibition of PKR. J. Virol. 79: 14562-14569 [Abstract] [Full Text]  
• Nanbo, A., Yoshiyama, H., Takada, K. (2005). Epstein-Barr Virus-Encoded Poly(A)- RNA Confers Resistance to Apoptosis Mediated through Fas by Blocking the PKR Pathway in Human Epithelial Intestine 407 Cells. J. Virol. 79: 12280-12285 [Abstract] [Full Text]  
• Poppema, S. (2005). Immunobiology and Pathophysiology of Hodgkin Lymphomas. ASH Education Book 2005: 231-238 [Abstract] [Full Text]